Chella Perumal Palanisamy

Dr. Chella Perumal Palanisamy

State Key Laboratory of Biobased Material and Green Papermaking, College of Food Science andEngineering, Qilu University of Technology, Shandong Academy of Science, Jinan 250353, China
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2024 in Frontiers in Nanotechnology
Verified
Journal Article
Open access
PDF file
RKRanil Vikraman Kumarasamy
Ranil Vikraman Kumarasamy
PNPrabhu Manickam Natarajan
Prabhu Manickam Natarajan
VUVidhya Rekha Umapathy
Vidhya Rekha Umapathy
JRJeane Rebecca Roy
Jeane Rebecca Roy
MMMonica MIRONESCU
Monica MIRONESCU
Chella Perumal PalanisamyChella Perumal Palanisamy
Chella Perumal Palanisamy
Nanoparticles are attractive therapeutic tools due to their distinctive characteristics, including more accurate drug delivery, improved bioavailability, and enhanced targeted therapy. This review offers a comprehensive analysis of the therapeutic potentials of cutting-edge nanoparticles as demonstrated in human clinical trials, based on empirical evidence. Through systematic searches of major scientific databases, relevant studies published up to March 2024 were included, focusing on clinical trials utilizing advanced nanoparticles for therapeutic purposes. The review discusses the diverse applications of nanoparticles in oncology, infectious diseases, neurology, and other medical fields. Additionally, it scrutinizes the safety profiles, efficacy outcomes, and challenges associated with nanoparticle-based therapies. The findings underscore significant progress in translating nanoparticle research into clinical practice and highlight the potential of these innovative platforms to revolutionize medical treatments. This review contributes valuable insights into the growing field of nanoparticle-based therapeutics, fostering a deeper understanding of their clinical applications and implications in medical practice.

22 June 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
JPJinjin Pei
Jinjin Pei
Chella Perumal PalanisamyChella Perumal Palanisamy
Chella Perumal Palanisamy
GSGuru Prasad Srinivasan
Guru Prasad Srinivasan
MPMani Panagal
Mani Panagal
Sathish Sundar Dhilip KumarSathish Sundar Dhilip Kumar
Sathish Sundar Dhilip Kumar
MMMonica MIRONESCU
Monica MIRONESCU

6 April 2021 in Molecules
Verified
Journal Article
Open access
PDF file
SJSelvaraj Jayaraman
Selvaraj Jayaraman
NDNALINI DEVARAJAN
NALINI DEVARAJAN
PRPonnulakshmi Rajagopal
Ponnulakshmi Rajagopal
SBshyamaladevi Babu
shyamaladevi Babu
GKG Senthil Kumar
G Senthil Kumar
KCKirubhanand Chandrasekar
Kirubhanand Chandrasekar
β-sitosterol (SIT), the most abundant bioactive component of vegetable oil and other plants, is a highly potent antidiabetic drug. Our previous studies show that SIT controls hyperglycemia and insulin resistance by activating insulin receptor and glucose transporter 4 (GLUT-4) in the adipocytes of obesity induced type 2 diabetic rats. The current research was undertaken to investigate if SIT could also exert its antidiabetic effects by circumventing adipocyte induced inflammation, a key driving factor for insulin resistance in obese individuals. Effective dose of SIT (20 mg/kg b.wt) was administered orally for 30 days to high fat diet and sucrose induced type-2 diabetic rats. Metformin, the conventionally used antidiabetic drug was used as a positive control. Interestingly, SIT treatment restores the elevated serum levels of proinflammatory cytokines including leptin, resistin, tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) to normalcy and increases anti-inflammatory adipocytokines including adiponectin in type 2 diabetic rats. Furthermore, SIT decreases sterol regulatory element binding protein-1c (SREBP-1c) and enhances Peroxisome Proliferator–activated receptor-γ (PPAR-γ) gene expression in adipocytes of diabetic rats. The gene and protein expression of c-Jun-N-terminal kinase-1 (JNK1), inhibitor of nuclear factor kappa-B kinase subunit beta (IKKβ) and nuclear factor kappa B (NF-κB) were also significantly attenuated in SIT treated groups. More importantly, SIT acts very effectively as metformin to circumvent inflammation and insulin resistance in diabetic rats. Our results clearly show that SIT inhibits obesity induced insulin resistance by ameliorating the inflammatory events in the adipose tissue through the downregulation of IKKβ/NF-κB and c-Jun-N-terminal kinase (JNK) signaling pathway.

28 February 2022 in Molecules
Verified
Journal Article
Open access
PDF file
MPMonisha Prasad
Monisha Prasad
SJSelvaraj Jayaraman
Selvaraj Jayaraman
Mohamed EladlMohamed Eladl
Mohamed Eladl
MEMohamed El-Sherbiny
Mohamed El-Sherbiny
MAMosaab Abdella Ebrahim Abdelrahman
Mosaab Abdella Ebrahim Abdelrahman
PRPonnulakshmi Rajagopal
Ponnulakshmi Rajagopal
Natural products in the form of functional foods have become increasingly popular due to their protective effects against life-threatening diseases, low risk of adverse effects, affordability, and accessibility. Plant components such as phytosterol, in particular, have drawn a lot of press recently due to a link between their consumption and a modest incidence of global problems, such as Type 2 Diabetes mellitus (T2DM), cancer, and cardiovascular disease. In the management of diet-related metabolic diseases, such as T2DM and cardiovascular disorders, these plant-based functional foods and nutritional supplements have unquestionably led the market in terms of cost-effectiveness, therapeutic efficacy, and safety. Diabetes mellitus is a metabolic disorder categoriszed by high blood sugar and insulin resistance, which influence major metabolic organs, such as the liver, adipose tissue, and skeletal muscle. These chronic hyperglycemia fallouts result in decreased glucose consumption by body cells, increased fat mobilisation from fat storage cells, and protein depletion in human tissues, keeping the tissues in a state of crisis. In addition, functional foods such as phytosterols improve the body’s healing process from these crises by promoting a proper physiological metabolism and cellular activities. They are plant-derived steroid molecules having structure and function similar to cholesterol, which is found in vegetables, grains, nuts, olive oil, wood pulp, legumes, cereals, and leaves, and are abundant in nature, along with phytosterol derivatives. The most copious phytosterols seen in the human diet are sitosterol, stigmasterol, and campesterol, which can be found in free form, as fatty acid/cinnamic acid esters or as glycosides processed by pancreatic enzymes. Accumulating evidence reveals that phytosterols and diets enriched with them can control glucose and lipid metabolism, as well as insulin resistance. Despite this, few studies on the advantages of sterol control in diabetes care have been published. As a basis, the primary objective of this review is to convey extensive updated information on the possibility of managing diabetes and associated complications with sterol-rich foods in molecular aspects.

18 July 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
JPJinJin Pei
JinJin Pei
Vidhya Rekha UmapathyVidhya Rekha Umapathy
Vidhya Rekha Umapathy
DVDr. Srinivasan V
Dr. Srinivasan V
SHShazia Fathima Jaffer Hussain
Shazia Fathima Jaffer Hussain
PRPonnulakshmi Rajagopal
Ponnulakshmi Rajagopal
GKGopinath Krishnasamy
Gopinath Krishnasamy
Diabetes mellitus has become a troublesome and increasingly widespread condition. Treatment strategies for diabetes prevention in high-risk as well as in affected individuals are largely attributed to improvements in lifestyle and dietary control. Therefore, it is important to understand the nutritional factors to be used in dietary intervention. A decreased risk of diabetes is associated with daily intake of millet-based foods. Pearl millet is a highly nutritious grain, nutritionally comparable and even superior in calories, protein, vitamins, and minerals to other large cereals, although its intake is confined to lower income segments of society. Pearl millet contains phenolic compounds which possess antidiabetic activity. Thus, it can be used to prepare a variety of food products for diabetes mellitus. Moreover, it also has many health benefits, including combating diabetes mellitus, cancer, cardiovascular conditions, decreasing tumour occurrence, lowering blood pressure, heart disease risk, cholesterol, and fat absorption rate. Therefore, the current review addresses the role of pearl millet in managing diabetes.

24 June 2024 in Ageing Research Reviews
Verified
Journal Article
Closed access
JPJinJin Pei
JinJin Pei
Chella Perumal PalanisamyChella Perumal Palanisamy
Chella Perumal Palanisamy
PNPrabhu Manickam Natarajan
Prabhu Manickam Natarajan
VUVidhya Rekha Umapathy
Vidhya Rekha Umapathy
JRJeane Rebecca Roy
Jeane Rebecca Roy
SJSelvaraj Jayaraman
Selvaraj Jayaraman